The latest advancements in Zika virus vaccine development
EXPERT REVIEW OF VACCINES (2017)
期刊
EXPERT REVIEW OF VACCINES
卷 16, 期 10, 页码 951-954出版社
TAYLOR & FRANCIS LTD
关键词
类别
资金
- NIAID NIH HHS [U19 AI171954] Funding Source: Medline
作者
我是这篇论文的作者
推荐
The Chimeric Binjari-Zika Vaccine Provides Long-Term Protection against ZIKA Virus Challenge
Jessamine E. Hazlewood, Bing Tang, Kexin Yan, Daniel J. Rawle, Jessica J. Harrison, Roy A. Hall, Jody Hobson-Peters, Andreas Suhrbier
VACCINES (2022)
A safe replication-defective Zika virus vaccine protects mice from viral infection and vertical transmission
Na Li, Cheng-Lin Deng, Qi Li, Xiao-Ling Chen, Bo Zhang, Han-Qing Ye
ANTIVIRAL RESEARCH (2023)
Enemy of My Enemy: A Novel Insect-Specific Flavivirus Offers a Promising Platform for a Zika Virus Vaccine
Danielle L. Porier, Sarah N. Wilson, Dawn I. Auguste, Andrew Leber, Sheryl Coutermarsh-Ott, Irving C. Allen, Clayton C. Caswell, James A. Budnick, Josep Bassaganya-Riera, Raquel Hontecillas, James Weger-Lucarelli, Scott C. Weaver, Albert J. Auguste
VACCINES (2021)
CpG content in the Zika virus genome affects infection phenotypes in the adult brain and fetal lymph nodes
Daniel Udenze, Ivan Trus, Nathalie Berube, Uladzimir Karniychuk
FRONTIERS IN IMMUNOLOGY (2022)
Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine
Noemia S. Lima, Damee Moon, Samuel Darko, Rafael A. De La Barrera, Leyi Lin, Michael A. Koren, Richard G. Jarman, Kenneth H. Eckels, Stephen J. Thomas, Nelson L. Michael, Kayvon Modjarrad, Daniel C. Douek, Lydie Trautmann
FRONTIERS IN IMMUNOLOGY (2021)
Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From Quillaja brasiliensis Enhances Anti-Zika Immune Responses, Including Neutralizing Antibodies and Splenocyte Proliferation
Samuel Cibulski, Ana Paula Muterle Varela, Thais Fumaco Teixeira, Martin Pablo Cancela, Patricia Sesterheim, Diogo Onofre Souza, Paulo Michel Roehe, Fernando Silveira
FRONTIERS IN IMMUNOLOGY (2021)
Zika virus dumbbell-1 structure is critical for sfRNA presence and cytopathic effect during infection
Monica E. Graham, Camille Merrick, Benjamin M. Akiyama, Matthew J. Szucs, Sarah Leach, Jeffery S. Kieft, J. David Beckham
MBIO (2023)
Effects of Statin Combinations on Zika Virus Infection in Vero Cells
Erica Espano, Jeong-Ki Kim
PHARMACEUTICS (2023)
BAF45b Is Required for Efficient Zika Virus Infection of HAP1 Cells
B. David Persson, Stefan Nord, Richard Lindqvist, Katarina Danskog, Anna K. Overby, Alain Kohl, Hugh J. Willison, Annasara Lenman, Niklas Arnberg
VIRUSES-BASEL (2021)
Evaluation of an Engineered Zika Virus-Like Particle Vaccine Candidate in a Mosquito-Mouse Transmission Model
Maria Vittoria Mancini, Rapeepat Tandavanitj, Thomas H. H. Ant, Shivan M. M. Murdochy, Daniel D. D. Gingell, Chayanee Setthapramote, Piyatida Natsrita, Alain Kohl, Steven P. P. Sinkins, Arvind H. H. Patel, Giuditta De Lorenzo
MSPHERE (2023)
Dengue, West Nile, and Zika Viruses: Potential Novel Antiviral Biologics Drugs Currently at Discovery and Preclinical Development Stages
Ivo C. C. Martins, Rafaela C. C. Ricardo, Nuno C. C. Santos
PHARMACEUTICS (2022)
Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge
Giuditta De Lorenzo, Rapeepat Tandavanitj, Jennifer Doig, Chayanee Setthapramote, Monica Poggianella, Ricardo Sanchez-Velazquez, Hannah E. Scales, Julia M. Edgar, Alain Kohl, James Brewer, Oscar R. Burrone, Arvind H. Patel
JOURNAL OF VIROLOGY (2021)
Genome Number and Size Polymorphism in Zika Virus Infectious Units
Nicole R. Sexton, Eric D. Bellis, Reyes A. Murrieta, Mark Cole Spangler, Parker J. Cline, James Weger-Lucarelli, Gregory D. Ebel
JOURNAL OF VIROLOGY (2021)
In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus
Zhong Li, Jimin Xu, Yuekun Lang, Xiangmeng Wu, Saiyang Hu, Subodh Kumar Samrat, Anil M. Tharappel, Lili Kuo, David Butler, Yongcheng Song, Qing-Yu Zhang, Jia Zhou, Hongmin Li
ACTA PHARMACEUTICA SINICA B (2022)
Amaryllidaceae Alkaloid Cherylline Inhibits the Replication of Dengue and Zika Viruses
Seydou Ka, Natacha Merindol, Aissatou Aicha Sow, Amita Singh, Karima Landelouci, Melodie B. Plourde, Genevieve Pepin, Marco Masi, Roberta Di Lecce, Antonio Evidente, Matar Seck, Lionel Berthoux, Laurent Chatel-Chaix, Isabel Desgagne-Penix
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
Xinling Wang, Wei Xu, Gaowei Hu, Shuai Xia, Zhiping Sun, Zezhong Liu, Youhua Xie, Rong Zhang, Shibo Jiang, Lu Lu
CELLULAR & MOLECULAR IMMUNOLOGY (2023)
Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
Shuai Xia, Jasper Fuk-Woo Chan, Lijue Wang, Fanke Jiao, Kenn Ka-Heng Chik, Hin Chu, Qiaoshuai Lan, Wei Xu, Qian Wang, Chao Wang, Kwok-Yung Yuen, Lu Lu, Shibo Jiang
CELL RESEARCH (2022)
Developing pan-β-coronavirus vaccines against emerging SARS-CoV-2 variants of concern
Shan Su, Weihua Li, Shibo Jiang
TRENDS IN IMMUNOLOGY (2022)
A Perspective on the Roles of Adjuvants in Developing Highly Potent COVID-19 Vaccines
Naru Zhang, Kangchen Li, Zezhong Liu, Kutty Selva Nandakumar, Shibo Jiang
VIRUSES-BASEL (2022)
A Toxin-Conjugated Recombinant Protein Targeting gp120 and gp41 for Inactivating HIV-1 Virions and Killing Latency-Reversing Agent-Reactivated Latent Cells
Xinling Wang, Wei Xu, Zezhong Liu, Yanling Wu, Qian Wang, Miao Cao, Tianlei Ying, Na He, Lu Lu, Shibo Jiang
MBIO (2022)
Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies
Xun Wang, Xiaoyu Zhao, Jieyu Song, Jing Wu, Yuqi Zhu, Minghui Li, Yuchen Cui, Yanjia Chen, Lulu Yang, Jun Liu, Huanzhang Zhu, Shibo Jiang, Pengfei Wang
EMERGING MICROBES & INFECTIONS (2022)
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody
Cheng Li, Wuqiang Zhan, Zhenlin Yang, Chao Tu, Gaowei Hu, Xiang Zhang, Wenping Song, Shujuan Du, Yuanfei Zhu, Keke Huang, Yu Kong, Meng Zhang, Qiyu Mao, Xiaodan Gu, Yi Zhang, Youhua Xie, Qiang Deng, Yuanlin Song, Zhenguo Chen, Lu Lu, Shibo Jiang, Yanling Wu, Lei Sun, Tianlei Ying
CELL (2022)
Design of artificial α-helical peptides targeting both gp41 deep pocket and subpocket as potent HIV-1 fusion inhibitors
Huan Wang, Xinling Wang, Jiahui Li, Qing Li, Siliang Feng, Lu Lu, Chao Wang, Shibo Jiang
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
A Protein-Based, Long-Acting HIV-1 Fusion Inhibitor with an Improved Pharmacokinetic Profile
Wei Xu, Zhe Cong, Qianyu Duan, Qian Wang, Shan Su, Rui Wang, Lu Lu, Jing Xue, Shibo Jiang
PHARMACEUTICALS (2022)
Rock1 is a novel host dependency factor of human enterovirus A71: Implication as a drug target
Xiaoyu Zhao, Cun Li, Man Chun Chiu, Rui Qiao, Shibo Jiang, Pengfei Wang, Jie Zhou
JOURNAL OF MEDICAL VIROLOGY (2022)
Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
Xiaoqing Guan, Yang Yang, Lanying Du
EXPERT REVIEW OF VACCINES (2023)
An Artificial Peptide-Based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-Helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane
Chao Wang, Qing Li, Lujia Sun, Xinling Wang, Huan Wang, Wenpeng Zhang, Jiahui Li, Yang Liu, Lu Lu, Shibo Jiang
VIRUSES-BASEL (2023)
A dePEGylated Lipopeptide-Based Pan-Coronavirus Fusion Inhibitor Exhibits Potent and Broad-Spectrum Anti-HIV-1 Activity without Eliciting Anti-PEG Antibodies
Ling Xu, Chao Wang, Wei Xu, Lixiao Xing, Jie Zhou, Jing Pu, Mingming Fu, Lu Lu, Shibo Jiang, Qian Wang
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
IgG Fc-Binding Peptide-Conjugated Pan-CoV Fusion Inhibitor Exhibits Extended In Vivo Half-Life and Synergistic Antiviral Effect When Combined with Neutralizing Antibodies
Xiaojie Su, Ziqi Huang, Wei Xu, Qian Wang, Lixiao Xing, Lu Lu, Shibo Jiang, Shuai Xia
BIOMOLECULES (2023)
Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge
Xiaoqing Guan, Abhishek K. Verma, Gang Wang, Juan Shi, Stanley Perlman, Lanying Du
ISCIENCE (2023)